Advanced Malignant Solid Tumors Completed Phase 1 Trials for Neratinib (DB11828)

IndicationStatusPhase
DBCOND0036787 (Advanced Malignant Solid Tumors)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01128842A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid TumorTreatment
NCT00768469Study Evaluating Safety And Tolerability, Solid TumorTreatment
NCT00958724Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid TumorsTreatment